RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Innovations in Oncology Diagnostics
Oct 2009 - 141 pages - $3,835
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Lixte Biotechnology Holdings, Inc. - Strategic SWOT Analysis Review
Dec 2010 - 18 pages - $125
Advancing Molecular Diagnostics to Personalize Cancer Therapy
Jun 2011 - 187 pages - $3,835
Nonmelanomatous Skin Cancer - Pipeline Review, Q4 2010
Dec 2010 - 26 pages - $500
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
Feb 2011 - 17 pages - $125
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
May 2011 - 20 pages - $125
Company Financials: Cougar Biotechnology, Inc.
Jan 2010 - $75
Molecular Targeted Cancer Therapies Market Forecast
Aug 2009 - $15,200
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human diagnostics del
Therapeutic target
Oncology del
Skin cancer del

Browse By

Therapeutic target
Basal cell carcinoma
Melanoma
Squamous cell carcinoma
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us